According to the adopted resolution, the Issuer’s Management Board will take all reasonable steps to ensure the Shareholders’ participation in the benefits of the potential sale of the technology to the widest possible extent. This includes the call by the potential buyer for all of the Issuer’s shares or allocating the entire profit obtained by the Company as a result of the potential sale of technology.
More information: https://www.parkiet.com/medycyna-i-zdrowie/art38165201-genomtec-chce-dopiescic-akcjonariuszy
